Malignant Musculoskeletal Neoplasm — Trials

Malignant Musculoskeletal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 141
Recruiting: 73
Ph III recruiting: 6
Growth YoY: −28%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (58)

clinicaltrialsPublishedShowing 201–204 of 204 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00520936	A Study of Pemetrexed in Children With Recurrent Cancer	completed	Phase 2	72	Eli Lilly and CompanyINDUSTRY	1	Feb 25, 2011	clinicaltrials
NCT00187109	Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy	completed	Phase 1 / Phase 2	40	St. Jude Children's Research HospitalOTHER	1	Apr 10, 2008	clinicaltrials